Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Infertility Treatment Market Outlook (2022 to 2032)

The global infertility treatment market size was valued at US$ 1.5 Billion in 2021 and is forecast to grow at a robust CAGR of 8% between 2022 and 2032, surpassing a valuation of US$ 3.5 Billion by the end of 2032. Growth in the infertility treatment market is driven by rising infertility rates across the globe and the growing popularity of advanced infertility treatments such as assisted reproductive technology.

Data Points Market Insights
Infertility Treatment Market Value 2021 USD 1.5 Billion
Infertility Treatment Market Value 2026 USD 2.2 Billion
Infertility Treatment Market Projected Value 2032 USD 3.5 Billion
Infertility Treatment Market Forecast CAGR (2022-2032) 8.0%
Key Players Thermo Fisher Scientific (USA), Cook Group (USA), Vitrolife (Sweden), IVFtech APS (Denmark), Hamilton Thorne Ltd. (USA), Esco Micro Pte Ltd. (Singapore), Genea Biomedx Ltd. (Australia), FUJIFILM Irvine Scientific (USA), and the Baker Company INC. (USA)

With global rates of male and female infertility continuing to rise drastically, demand for infertility treatments is slated to grow at a healthy pace during the forecast period. People who are unable to conceive naturally are opting for infertility treatments like artificial insemination assisted reproductive technology, and fertility surgeries.

Over the years, there has been a significant rise in the number of fertility clinics and hospitals across the globe that provide a wide range of advanced reproductive technologies to sterile people and help them to conceive children.

The inability to produce children can lead to emotional disturbance, depression, and several other serious consequences. As a result, people with infertility problems are increasingly opting for assisted reproductive technology procedures. Rising awareness about the benefits of these reproductive technologies will continue to encourage their adoption during the forecast period. It is estimated that over 5 million children worldwide are born from ART intervention as per the World Health Organization (WHO).

Similarly, the growing popularity of stem cell-based therapies for the treatment of male infertility and increasing investments in research and development activities for exploring novel approaches for infertility treatment will boost market growth during the forthcoming years. For instance, in 2021 research at the University of Georgia successfully developed sperm cells from primate cells that provides hope for future clinical therapies.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2015 to 2021 Market Demand Outlook for Infertility Treatment Compared to 2022 to 2032 Forecast

The global demand for infertility treatments is slated to grow at a healthy CAGR of 8% during the forecast period between 2022 and 2032. Factors such as the declining global fertility rate, the surge in the number of infertility centers, the higher success rate of advanced reproductive technologies, growing medical tourism, and increasing support from the government and other healthcare organizations are driving growth in the global infertility treatment market.

Infertility treatments are reproductive medical techniques and procedures employed to help people achieve pregnancy when natural conception is not feasible. They have been in use for a long time now. However, the introduction of assisted reproductive technology (ART) has completely transformed the global infertility treatment market in recent years. Today, most people who are not able to conceive naturally opt for advanced reproductive technologies like in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), and intracytoplasmic sperm injection due to their higher success rates.

The rapid decline in global fertility rates due to factors such as excessive usage of contraceptives, delayed marriages, the presence of various diseases, etc., is acting as a catalyst for the growth of the infertility treatment market. According to the World Fertility and Family Planning 2020 report of the Population Division of the United Nations Department of Economic and Social Affairs (UN DESA), the global fertility rate is expected to continue to fall from 2.5 live births per woman today to 2.2 in 2050. This will continue to expand the infertility treatment market size during the forthcoming years.

Growing health awareness is another factor augmenting the infertility treatment market growth. Leading market players and healthcare organizations are continuously putting efforts into educating the masses about infertility, its consequences, and the availability of various treatments. For instance, Oasis Fertility launched a new online portal for IVF treatment. Similarly, in 2021 EMD Serono launched a new fertility LifeLines Portal to increase support and access for patients with infertility.

Similarly, the rapid growth of cryopreservation for the in-vitro fertilization (IVF) market, rising infertility testing rates, and booming medical tourism sector will create opportunities for infertility treatment companies during the forecast period.

Developing countries like China and India are experiencing huge demand for infertility treatments due to the availability of low-cost IVF treatment and ICSI treatments. Growing medical tourism across these countries will eventually increase the infertility treatment devices market share during the forecast period.

Which Factors are Challenging the Growth of Infertility Treatment Market?

Despite a positive growth outlook, the global infertility treatment market is facing various challenges that are slowing down its growth to some extent. Some of these challenges are the high cost of assisted reproductive technology (ART) procedures, the lack of reimbursement policies across the majority of the regions, ethical considerations and limitations on ART procedures, and the presence of stringent regulations on the use of ART.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Why is the United Kingdom Considered a Prominent Infertility Treatment Market?

Decreasing Fertility Rate Creating Growth Prospects for Infertility Treatment Market in the United Kingdom

As per Future Market Insights, the United Kingdom will continue to remain the most lucrative market for infertility treatments, owing to the declining fertility rate, the heavy presence of leading infertility treatment clinics and highly qualified professionals, the growing popularity of assisted reproductive technology due to its higher success rate, and flourishing surrogacy tourism.

Over the years, there has been a rapid decline in the fertility rate across the United Kingdom which in turn is creating space for infertility treatment market growth. According to Office for National Statistics, the total fertility rate (TFR) reached a record low of 1.59 children per woman in England in 2020.

Similarly, heavy penetration of infertility treatment clinics and IVF centers across the United Kingdom is boosting the growth of the infertility treatment market and the trend is likely to continue in the future.

What are the Growth Projections for the USA Market?

Rising Adoption of Assisted Reproductive Technology Spurring Infertility Treatment Market Growth in the USA

The USA infertility treatment market is poised to exhibit strong growth during the forecast period from 2022 to 2032, owing to the rising cases of infertility due to polycystic ovary syndrome (PCOS), the rapidly evolving healthcare industry, easy availability of in vitro fertilization banking services, presence of leading market players, growing adoption of advanced technologies, and rapid expansion of donor egg IVF (in-vitro fertilization) market.

The rising prevalence of POCS cases in the USA has resulted in an increase in infertility rates across the USA As per the Centers for Disease Control and Prevention (CDC), PCOS is one of the most common causes of female infertility in the USA affecting 6% to 12% of women of reproductive age. This will continue to generate demand for infertility treatments, thereby boosting the growth of the USA IVF market during the forecast period.

Similarly, the growing adoption of assisted reproductive techniques such as IVF and GIFT due to their higher success rates is augmenting the growth of the infertility treatment market in the USA Each year thousands of infants born in the USA are conceived by using ART.

Category-wise Segment

Which Product Contributes Most to the Infertility Treatment Market?

Demand for Media and Consumables Will Continue to Remain High in the Global Infertility Treatment Market

Based on product, the global infertility treatment market has been segmented into equipment, media & consumables, and accessories. Among these, the media & consumable segment accounts for the largest share of the infertility treatment market. This is attributed to growing consumer preference for infertility treatment drugs as the first line of treatment due to their easy availability and low-cost nature. Similarly, increasing usage of different types of media to culture embryos coupled with the expansion of IVF devices and the consumables market will further boost the growth of this segment during the forecast period.

Why is Demand for Assisted Reproductive Technology Rising Across the World?

High Success Rate of Assisted Reproductive Technology Encouraging its Adoption

By procedure, the infertility treatment market is segmented into assisted reproductive technology, artificial insemination, fertility surgeries, and others. Among these, artificial insemination held a significant share of the global infertility treatment market in 2020. However, with advancements in reproductive technology and rising consumer inclination towards treatments like in vitro fertilization due to their various advantages, the assisted reproductive technology (ART) segment is expected to outpace the artificial insemination segment during the forecast period.

People are increasingly opting for assisted reproductive technology on account of its higher success rate and rising institutional financial support. As per the Centers for Disease Control and Prevention (CDC), nearly 2.1% of all infants born in the USA every year are conceived using assisted reproduction technology. Driven by this, the latest infertility treatment market trends indicate that the ART segment will grow at a faster CAGR over the assessment period.

Similarly, the growing popularity of modified IVF versions such as gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT) coupled with advancements in in-vitro fertilization monitoring (IVF) systems and expansion of assisted reproductive technology market across developed and developing regions will further support the growth of this segment.

Which Segment by Patient Type is a Major Contributor to the Infertility Treatment Market?

Demand for Infertility Treatments Among Females Remains High

As per FMI, the female infertility treatment segment accounts for the largest revenue share in the global infertility market and the trend is likely to continue during the forecast period, owing to the high female infertility rate worldwide caused by obesity, unhealthy lifestyle, and disorders like polycystic ovary syndrome (PCOS).

However, the increasing incidence of male sterility and the rapid expansion of the male infertility treatment market is expected to generate growth opportunities in the male infertility treatment segment during the forecast period.

Who is the Leading End User for Infertility Treatments?

Infertility Centers Becoming Ideal Destination for Infertility Treatments

Based on end-user, the infertility treatment market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. Among these, the fertility centers segment dominated the global infertility treatment market in 2021 and is likely to retain its top position during the forecast period. The rapid surge in the number of fertility centers worldwide, the presence of advanced reproductive technologies in fertility centers, and various attractive infertility treatment packages offered by these fertility centers are triggering the growth of this segment.

Fertility centers deal with both natural remedies and medical treatment to increase sperm count, thereby becoming the first choice for male patients.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

Leading infertility treatment providers are continuously focusing on expanding their infertility treatment product offerings and services to woo more and more customers. Further, they have adopted various strategies such as partnerships, acquisitions, mergers collaborations, the launch of awareness campaigns and advertisements, and the establishment of new infertility treatment centers and clinics to gain a competitive edge in the global infertility treatment market. For instance,

  • In August 2021, Merck Specialties Pvt ltd launched Pergoveris Pen for advanced infertility treatment in India.
  • In 2022, Vios Fertility Institute in partnership with TMRW Life Sciences launched state-of-art Cryo management solutions for fertility specimens.
  • In 2019, Thermo Fisher Scientific collaborated with Predictive Laboratories to advance fertility research
  • In September 2019, Hamilton Thorne Ltd. Received FDA clearance for marketing its first Gynemed (GYNEMED GM501) in the USA

Scope of Report

FMI’s latest infertility treatment market report analyzes the historical and present-day scenario of the global infertility treatment market to accurately gauge its potential future development. It highlights the key market dynamics including revenue growth drivers, restraints, opportunities, challenges, emerging market trends, product innovations, demand and supply graphs, and changing consumer preferences.

The report breaks down and analyzes the market segments to provide a better assessment of the top-scoring segments in the global infertility treatment market. It explains how the rise in infertility rates is igniting the demand for treatments like assisted reproductive technology.

FMI also attempts to highlight the impact of the flourishing in vitro fertilization market on the overall demand for infertility treatments and explains how the high success rate of IVF is giving hope to childless parents. The report has been interspersed with relevant statistics and graphs to make it more interesting.

The Infertility Treatment Market analysis includes:

  • A 10-year realistic infertility treatment sales forecast slicing across multiple verticals
  • Key consumer dynamics that may impact demand for infertility treatments during upcoming years
  • A detailed discussion on the impact of surging infertility rates on the infertility treatment market size
  • Top infertility treatment companies and their respective growth strategies.
  • Compelling insights into potential markets and leading product segments along with their respective shares and growth forecast.
  • Information about the latest fertility tracking apps and their role in supporting infertility treatment market growth
  • In-depth analysis of supply and demand ratio, growth revenue, supply chain analysis, and business overview
  • Key insights into the latest infertility treatment market trends
  • Market dynamics including drivers, restraints, and emerging opportunities
  • The winning imperatives in the infertility treatment market
Attribute Details
Forecast Period 2022 to 2032
Historical Data Available for 2015 to 2021
Market Analysis USD Million for Value and MT for Volume
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Key Segments Covered
  • Product Type
  • Procedure
  • Patient Type
  • End User
  • Region
Key regions covered North America
  • USA
  • Canada
  • Rest of North America
Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
Western Europe
  • Germany
  • United Kingdom
  • France
  • Rest of Western Europe
Eastern Europe
  • Russia
  • Spain
  • Rest of Eastern Europe
South Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • Thailand
  • Indonesia
  • South Korea
  • Rest of South Asia & Pacific
Middle East & Africa
  • GCC Countries
  • Turkey
  • Israel
  • Rest of the Middle East and Africa(MEA)
Rest of the World
  • Oceania
  • Africa
  • South America
End User
  • Fertility Centre’s
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes
Key Companies Covered Thermo Fisher Scientific (USA), Cook Group (USA), Vitrolife (Sweden), IVFtech APS (Denmark), Hamilton Thorne Ltd. (USA), Esco Micro Pte Ltd. (Singapore), Genea Biomedx Ltd. (Australia), FUJIFILM Irvine Scientific (USA), and the Baker Company INC. (USA)
Customization & Pricing Available upon Request

Key Segments

By Product:

  • Equipment
    • Microscopes
    • Imaging Systems
    • Sperm Analyser Systems
    • Ovum Aspiration Pumps
    • Micromanipulator Systems
    • Incubators
    • Gas Analyzers
    • Laser Systems
    • Cryosystems
    • Sperm Separation Devices
  • Media & Consumables
  • Accessories

By Procedure:

  • Assisted Reproductive Technology
    • In Vitro Fertilization
      • Intracytoplasmic Morphologically Selected Sperm Injection
      • Gamete Donation
    • Intracytoplasmic Sperm Injection
    • Surrogacy
  • Artificial Insemination
    • Intrauterine Insemination
    • Intracervical Insemination
    • Intratubal Insemination
  • Fertility Surgeries
    • Laparoscopy
    • Hysteriscopy
    • Varicocelectomy
    • Laparotomy
    • Tubal Ligation Reversal
    • Microsurgical Reconstruction
      • Vasovasostomy
      • Vasoepididymostomy
  • Other Infertility Treatment Procedures

By Patient Type:

  • Female Infertility Treatment
  • Male Infertility Treatment

By End User:

  • Fertility Centres
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

How much was the global infertility treatment market worth in 2021?

The global infertility market valuation reached over US$ 1.5 Billion in 2021.

What is the estimated market valuation of infertility treatment market?

As per FMI, global infertility treatment is likely to expand at 8% CAGR during the forecast period, totaling a valuation of US$ 3.5 Billion by 2032.

Which region holds maximum potential for infertility treatment market growth?

The Asia Pacific region is likely to continue dominating the global infertility market owing to the high adoption rate and growing health awareness among people.

Which are some prominent players operating in the infertility treatment market?

Thermo Fisher Scientific (USA), Cook Group (USA), Vitrolife (Sweden), IVFtech APS (Denmark), Hamilton Thorne Ltd. (USA), Esco Micro Pte Ltd. (Singapore), Genea Biomedx Ltd. (Australia), FUJIFILM Irvine Scientific (USA), and the Baker Company INC. (USA) are some of the prominent market players operating in the infertility treatment market.

Table of Content

1. Executive Summary | Infertility Treatment Market

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. FMI Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage

    2.2. Market Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Million)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Market, by Key Countries

    4.2. Market Opportunity Assessment (US$ Million)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in Optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032

    6.1. Historical Market Analysis, 2015 to 2021

    6.2. Current and Future Market Projections, 2022 to 2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032

    7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021

    7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million) Analysis By Product, 2015 to 2021

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032

        8.3.1. Equipment

            8.3.1.1. Microscopes

            8.3.1.2. Imaging Systems

            8.3.1.3. Sperm Analyzer Systems

            8.3.1.4. Ovum Aspiration Pumps

            8.3.1.5. Micromanipulator Systems

            8.3.1.6. Incubators

            8.3.1.7. Gas Analyzers

            8.3.1.8. Laser Systems

            8.3.1.9. Cryosystems

            8.3.1.10. Sperm Separation Devices

        8.3.2. Media & Consumables

        8.3.3. Accessories

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Procedure

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis By Procedure, 2015 to 2021

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2022 to 2032

        9.3.1. Assisted Reproductive Technology

            9.3.1.1. In Vitro Fertilization

                9.3.1.1.1. Intracytoplasmic Morphologically Selected Sperm Injection

                9.3.1.1.2. Gamete Donation

            9.3.1.2. Intracytoplasmic Sperm Injection

            9.3.1.3. Surrogacy

        9.3.2. Artificial Insemination

            9.3.2.1. Intrauterine Insemination

            9.3.2.2. Intracervical Insemination

            9.3.2.3. Intratubal Insemination

        9.3.3. Fertility Surgeries

            9.3.3.1. Laparoscopy

            9.3.3.2. Hysteroscopy

            9.3.3.3. Varicocelectomy

            9.3.3.4. Laparotomy

            9.3.3.5. Tubal Ligation Reversal

            9.3.3.6. Varicocelectomy

            9.3.3.7. Microsurgical Reconstruction

                9.3.3.7.1. Vasovasostomy

                9.3.3.7.2. Vasoepididymostomy

        9.3.4. Other Procedures

    9.4. Market Attractiveness Analysis By Procedure

10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Patient type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Patient Type, 2015 to 2021

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Patient Type, 2022 to 2032

        10.3.1. Female

        10.3.2. Male

    10.4. Market Attractiveness Analysis By Patient Type

11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2021

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032

        11.3.1. Fertility Centers

        11.3.2. Hospitals & Surgical Clinics

        11.3.3. Cryobanks

        11.3.4. Research Institutes

    11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021

    12.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Asia Pacific

        12.3.5. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        13.4.1. By Country

            13.4.1.1. USA

            13.4.1.2. Canada

            13.4.1.3. Rest of North America

        13.4.2. By Product

        13.4.3. By Procedure

        13.4.4. By End User

        13.4.5. By Patient type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product

        13.5.3. By Procedure

        13.5.4. By End User

        13.5.5. By Patient type

14. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        14.4.1. By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Rest of Latin America

        14.4.2. By Product

        14.4.3. By Procedure

        14.4.4. By End User

        14.4.5. By Patient type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By Procedure

        14.5.4. By End User

        14.5.5. By Patient type

15. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. France

            15.4.1.3. United Kingdom

            15.4.1.4. Italy

            15.4.1.5. Benelux

            15.4.1.6. Nordic Countries

            15.4.1.7. Rest of Europe

        15.4.2. By Product

        15.4.3. By Procedure

        15.4.4. By End User

        15.4.5. By Patient type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By Procedure

        15.5.4. By End User

        15.5.5. By Patient type

16. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    16.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        16.4.1. By Country

            16.4.1.1. China

            16.4.1.2. Japan

            16.4.1.3. South Korea

            16.4.1.4. Rest of Asia Pacific

        16.4.2. By Product

        16.4.3. By Procedure

        16.4.4. By End User

        16.4.5. By Patient type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By Procedure

        16.5.4. By End User

        16.5.5. By Patient type

17. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021

    17.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032

        17.4.1. By Country

            17.4.1.1. GCC Countries

            17.4.1.2. South Africa

            17.4.1.3. Turkey

            17.4.1.4. Rest of Middle East and Africa

        17.4.2. By Product

        17.4.3. By Procedure

        17.4.4. By End User

        17.4.5. By Patient type

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product

        17.5.3. By Procedure

        17.5.4. By End User

        17.5.5. By Patient type

18. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. USA Market Analysis

        18.2.1. Value Proportion Analysis by Market Taxonomy

        18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.2.2.1. By Product

            18.2.2.2. By Procedure

            18.2.2.3. By End User

            18.2.2.4. By Patient type

    18.3. Canada Market Analysis

        18.3.1. Value Proportion Analysis by Market Taxonomy

        18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.3.2.1. By Product

            18.3.2.2. By Procedure

            18.3.2.3. By End User

            18.3.2.4. By Patient type

    18.4. Mexico Market Analysis

        18.4.1. Value Proportion Analysis by Market Taxonomy

        18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.4.2.1. By Product

            18.4.2.2. By Procedure

            18.4.2.3. By End User

            18.4.2.4. By Patient type

    18.5. Brazil Market Analysis

        18.5.1. Value Proportion Analysis by Market Taxonomy

        18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.5.2.1. By Product

            18.5.2.2. By Procedure

            18.5.2.3. By End User

            18.5.2.4. By Patient type

    18.6. Germany Market Analysis

        18.6.1. Value Proportion Analysis by Market Taxonomy

        18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.6.2.1. By Product

            18.6.2.2. By Procedure

            18.6.2.3. By End User

            18.6.2.4. By Patient type

    18.7. France Market Analysis

        18.7.1. Value Proportion Analysis by Market Taxonomy

        18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.7.2.1. By Product

            18.7.2.2. By Procedure

            18.7.2.3. By End User

            18.7.2.4. By Patient type

    18.8. Italy Market Analysis

        18.8.1. Value Proportion Analysis by Market Taxonomy

        18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.8.2.1. By Product

            18.8.2.2. By Procedure

            18.8.2.3. By End User

            18.8.2.4. By Patient type

    18.9. BENELUX Market Analysis

        18.9.1. Value Proportion Analysis by Market Taxonomy

        18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.9.2.1. By Product

            18.9.2.2. By Procedure

            18.9.2.3. By End User

            18.9.2.4. By Patient type

    18.10. United Kingdom Market Analysis

        18.10.1. Value Proportion Analysis by Market Taxonomy

        18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.10.2.1. By Product

            18.10.2.2. By Procedure

            18.10.2.3. By End User

            18.10.2.4. By Patient type

    18.11. Nordic Countries Market Analysis

        18.11.1. Value Proportion Analysis by Market Taxonomy

        18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.11.2.1. By Product

            18.11.2.2. By Procedure

            18.11.2.3. By End User

            18.11.2.4. By Patient type

    18.12. China Market Analysis

        18.12.1. Value Proportion Analysis by Market Taxonomy

        18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.12.2.1. By Product

            18.12.2.2. By Procedure

            18.12.2.3. By End User

            18.12.2.4. By Patient type

    18.13. Japan Market Analysis

        18.13.1. Value Proportion Analysis by Market Taxonomy

        18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.13.2.1. By Product

            18.13.2.2. By Procedure

            18.13.2.3. By End User

            18.13.2.4. By Patient type

    18.14. South Korea Market Analysis

        18.14.1. Value Proportion Analysis by Market Taxonomy

        18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.14.2.1. By Product

            18.14.2.2. By Procedure

            18.14.2.3. By End User

            18.14.2.4. By Patient type

    18.15. GCC Countries Market Analysis

        18.15.1. Value Proportion Analysis by Market Taxonomy

        18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.15.2.1. By Product

            18.15.2.2. By Procedure

            18.15.2.3. By End User

            18.15.2.4. By Patient type

    18.16. South Africa Market Analysis

        18.16.1. Value Proportion Analysis by Market Taxonomy

        18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.16.2.1. By Product

            18.16.2.2. By Procedure

            18.16.2.3. By End User

            18.16.2.4. By Patient type

    18.17. Turkey Market Analysis

        18.17.1. Value Proportion Analysis by Market Taxonomy

        18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032

            18.17.2.1. By Product

            18.17.2.2. By Procedure

            18.17.2.3. By End User

            18.17.2.4. By Patient type

        18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional Footprint of Players

        19.4.2. Product Footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. The Cooper Companies, Inc.

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Strategy Overview

        20.3.2. Cook Group

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Strategy Overview

        20.3.3. Vitrolife

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Strategy Overview

        20.3.4. Thermo Fisher Scientific

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Strategy Overview

        20.3.5. Hamilton Thorne LTD

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Strategy Overview

        20.3.6. Esco Micro Pte Ltd

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Strategy Overview

        20.3.7. Genea Limited

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Strategy Overview

        20.3.8. IVFtech APS

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Strategy Overview

        20.3.9. FUJIFILM Irvine Scientific

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Strategy Overview

        20.3.10. The Baker Company INC

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million), By Product, 2015 to 2021

Table 2: Global Market Value (US$ Million), By Product, 2022 to 2032

Table 3: Global Market Value (US$ Million), By Procedure, 2015 to 2021

Table 4: Global Market Value (US$ Million), By Procedure, 2022 to 2032

Table 5: Global Market Value (US$ Million), By Patient Type, 2015 to 2021

Table 6: Global Market Value (US$ Million), By Patient Type, 2022 to 2032

Table 7: Global Market Value (US$ Million), By End User, 2015 to 2021

Table 8: Global Market Value (US$ Million), By End User, 2022 to 2032

Table 9: Global Market, By Region, 2015 to 2021

Table 10: Global Market, By Region, 2022 to 2032

Table 11: North America Market Value (US$ Million), By Product, 2015 to 2021

Table 12: North America Market Value (US$ Million), By Product, 2022 to 2032

Table 13: North America Market Value (US$ Million), By Procedure, 2015 to 2021

Table 14: North America Market Value (US$ Million), By Procedure, 2022 to 2032

Table 15: North America Market Value (US$ Million), By Patient Type, 2015 to 2021

Table 16: North America Market Value (US$ Million), By Patient Type, 2022 to 2032

Table 17: North America Market Value (US$ Million), By End User, 2015 to 2021

Table 18: North America Market Value (US$ Million), By End User, 2022 to 2032

Table 19: North America Market, By Country, 2015 to 2021

Table 20: North America Market, By Country, 2022 to 2032

Table 21: Latin America Market Value (US$ Million), By Product, 2015 to 2021

Table 22: Latin America Market Value (US$ Million), By Product, 2022 to 2032

Table 23: Latin America Market Value (US$ Million), By Procedure, 2015 to 2021

Table 24: Latin America Market Value (US$ Million), By Procedure, 2022 to 2032

Table 25: Latin America Market Value (US$ Million), By Patient Type, 2015 to 2021

Table 26: Latin America Market Value (US$ Million), By Patient Type, 2022 to 2032

Table 27: Latin America Market Value (US$ Million), By End User, 2015 to 2021

Table 28: Latin America Market Value (US$ Million), By End User, 2022 to 2032

Table 29: Latin America Market, By Country, 2015 to 2021

Table 30: Latin America Market, By Country, 2022 to 2032

Table 31: Europe Market Value (US$ Million), By Product, 2015 to 2021

Table 32: Europe Market Value (US$ Million), By Product, 2022 to 2032

Table 33: Europe Market Value (US$ Million), By Procedure, 2015 to 2021

Table 34: Europe Market Value (US$ Million), By Procedure, 2022 to 2032

Table 35: Europe Market Value (US$ Million), By Patient Type, 2015 to 2021

Table 36: Europe Market Value (US$ Million), By Patient Type, 2022 to 2032

Table 37: Europe Market Value (US$ Million), By End User, 2015 to 2021

Table 38: Europe Market Value (US$ Million), By End User, 2022 to 2032

Table 39: Europe Market, By Country, 2015 to 2021

Table 40: Europe Market, By Country, 2022 to 2032

Table 41: Asia Pacific Market Value (US$ Million), By Product, 2015 to 2021

Table 42: Asia Pacific Market Value (US$ Million), By Product, 2022 to 2032

Table 43: Asia Pacific Market Value (US$ Million), By Procedure, 2015 to 2021

Table 44: Asia Pacific Market Value (US$ Million), By Procedure, 2022 to 2032

Table 45: Asia Pacific Market Value (US$ Million), By Patient Type, 2015 to 2021

Table 46: Asia Pacific Market Value (US$ Million), By Patient Type, 2022 to 2032

Table 47: Asia Pacific Market Value (US$ Million), By End User, 2015 to 2021

Table 48: Asia Pacific Market Value (US$ Million), By End User, 2022 to 2032

Table 49: Asia Pacific Market, By Country, 2015 to 2021

Table 50: Asia Pacific Market, By Country, 2022 to 2032

Table 51: MEA Market Value (US$ Million), By Product, 2015 to 2021

Table 52: MEA Market Value (US$ Million), By Product, 2022 to 2032

Table 53: MEA Market Value (US$ Million), By Procedure, 2015 to 2021

Table 54: MEA Market Value (US$ Million), By Procedure, 2022 to 2032

Table 55: MEA Market Value (US$ Million), By Patient Type, 2015 to 2021

Table 56: MEA Market Value (US$ Million), By Patient Type, 2022 to 2032

Table 57: MEA Market Value (US$ Million), By End User, 2015 to 2021

Table 58: MEA Market Value (US$ Million), By End User, 2022 to 2032

Table 59: MEA Market, By Country, 2015 to 2021

Table 60: MEA Market, By Country, 2022 to 2032
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032

Figure 2: Global Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million

Figure 3: Global Market Share, By Product, 2022 & 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Product – 2022 to 2032

Figure 5: Global Market Attractiveness Index, By Product – 2022 to 2032

Figure 6: Global Market Share, By Procedure, 2022 & 2032

Figure 7: Global Market Y-o-Y Growth Projections, By Procedure – 2022 to 2032

Figure 8: Global Market Attractiveness Index, By Procedure – 2022 to 2032

Figure 9: Global Market Share, By End User, 2022 & 2032

Figure 10: Global Market Y-o-Y Growth Projections, By End User – 2022 to 2032

Figure 11: Global Market Attractiveness Index, By End User – 2022 to 2032

Figure 12: Global Market Share, By Patient Type, 2022 & 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032

Figure 14: Global Market Attractiveness Index, By Patient Type – 2022 to 2032

Figure 15: Global Market Share, By Region, 2022 & 2032

Figure 16: Global Market Y-o-Y Growth Projections, By Region – 2022 to 2032

Figure 17: Global Market Attractiveness Index, By Region – 2022 to 2032

Figure 18: North America Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032

Figure 19: North America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 20: North America Market Share, By Product, 2022 & 2032

Figure 21: North America Market Y-o-Y Growth Projections, By Product – 2022 to 2032

Figure 22: North America Market Attractiveness Index, By Product – 2022 to 2032

Figure 23: North America Market Share, By Procedure, 2022 & 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Procedure – 2022 to 2032

Figure 25: North America Market Attractiveness Index, By Procedure – 2022 to 2032

Figure 26: North America Market Share, By End User, 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By End User – 2022 to 2032

Figure 28: North America Market Attractiveness Index, By End User – 2022 to 2032

Figure 29: North America Market Share, By Patient Type, 2022 & 2032

Figure 30: North America Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032

Figure 31: North America Market Attractiveness Index, By Patient Type – 2022 to 2032

Figure 32: North America Market Share, By Country, 2022 & 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022 to 2032

Figure 34: North America Market Attractiveness Index, By Country – 2022 to 2032

Figure 35: Latin America Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032

Figure 36: Latin America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 37: Latin America Market Share, By Product, 2022 & 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Product – 2022 to 2032

Figure 39: Latin America Market Attractiveness Index, By Product – 2022 to 2032

Figure 40: Latin America Market Share, By Procedure, 2022 & 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Procedure – 2022 to 2032

Figure 42: Latin America Market Attractiveness Index, By Procedure – 2022 to 2032

Figure 43: Latin America Market Share, By End User, 2022 & 2032

Figure 44: Latin America Market Y-o-Y Growth Projections, By End User – 2022 to 2032

Figure 45: Latin America Market Attractiveness Index, By End User – 2022 to 2032

Figure 46: Latin America Market Share, By Patient Type, 2022 & 2032

Figure 47: Latin America Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032

Figure 48: Latin America Market Attractiveness Index, By Patient Type – 2022 to 2032

Figure 49: Latin America Market Share, By Country, 2022 & 2032

Figure 50: Latin America Market Y-o-Y Growth Projections, By Country – 2022 to 2032

Figure 51: Latin America Market Attractiveness Index, By Country – 2022 to 2032

Figure 52: Europe Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032

Figure 53: Europe Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 54: Europe Market Share, By Product, 2022 & 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Product – 2022 to 2032

Figure 56: Europe Market Attractiveness Index, By Product – 2022 to 2032

Figure 57: Europe Market Share, By Procedure, 2022 & 2032

Figure 58: Europe Market Y-o-Y Growth Projections, By Procedure – 2022 to 2032

Figure 59: Europe Market Attractiveness Index, By Procedure – 2022 to 2032

Figure 60: Europe Market Share, By End User, 2022 & 2032

Figure 61: Europe Market Y-o-Y Growth Projections, By End User – 2022 to 2032

Figure 62: Europe Market Attractiveness Index, By End User – 2022 to 2032

Figure 63: Europe Market Share, By Patient Type, 2022 & 2032

Figure 64: Europe Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032

Figure 65: Europe Market Attractiveness Index, By Patient Type – 2022 to 2032

Figure 66: Europe Market Share, By Country, 2022 & 2032

Figure 67: Europe Market Y-o-Y Growth Projections, By Country – 2022 to 2032

Figure 68: Europe Market Attractiveness Index, By Country – 2022 to 2032

Figure 69: MEA Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032

Figure 70: MEA Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 71: MEA Market Share, By Product, 2022 & 2032

Figure 72: MEA Market Y-o-Y Growth Projections, By Product – 2022 to 2032

Figure 73: MEA Market Attractiveness Index, By Product – 2022 to 2032

Figure 74: MEA Market Share, By Procedure, 2022 & 2032

Figure 75: MEA Market Y-o-Y Growth Projections, By Procedure – 2022 to 2032

Figure 76: MEA Market Attractiveness Index, By Procedure – 2022 to 2032

Figure 77: MEA Market Share, By End User, 2022 & 2032

Figure 78: MEA Market Y-o-Y Growth Projections, By End User – 2022 to 2032

Figure 79: MEA Market Attractiveness Index, By End User – 2022 to 2032

Figure 80: MEA Market Share, By Patient Type, 2022 & 2032

Figure 81: MEA Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032

Figure 82: MEA Market Attractiveness Index, By Patient Type – 2022 to 2032

Figure 83: MEA Market Share, By Country, 2022 & 2032

Figure 84: MEA Market Y-o-Y Growth Projections, By Country – 2022 to 2032

Figure 85: MEA Market Attractiveness Index, By Country – 2022 to 2032

Figure 86: Asia Pacific Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032

Figure 87: Asia Pacific Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million

Figure 88: Asia Pacific Market Share, By Product, 2022 & 2032

Figure 89: Asia Pacific Market Y-o-Y Growth Projections, By Product – 2022 to 2032

Figure 90: Asia Pacific Market Attractiveness Index, By Product – 2022 to 2032

Figure 91: Asia Pacific Market Share, By Procedure, 2022 & 2032

Figure 92: Asia Pacific Market Y-o-Y Growth Projections, By Procedure – 2022 to 2032

Figure 93: Asia Pacific Market Attractiveness Index, By Procedure – 2022 to 2032

Figure 94: Asia Pacific Market Share, By End User, 2022 & 2032

Figure 95: Asia Pacific Market Y-o-Y Growth Projections, By End User – 2022 to 2032

Figure 96: Asia Pacific Market Attractiveness Index, By End User – 2022 to 2032

Figure 97: Asia Pacific Market Share, By Patient Type, 2022 & 2032

Figure 98: Asia Pacific Market Y-o-Y Growth Projections, By Patient Type – 2022 to 2032

Figure 99: Asia Pacific Market Attractiveness Index, By Patient Type – 2022 to 2032

Figure 100: Asia Pacific Market Share, By Country, 2022 & 2032

Figure 101: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022 to 2032

Figure 102: Asia Pacific Market Attractiveness Index, By Country – 2022 to 2032

Recommendations

Healthcare

Phototherapy Treatment Market

Published : November 2023

Healthcare

Leukemia Therapeutics Treatment Market

Published : October 2023

Healthcare

Kids Sports Injury Treatment Market

Published : November 2022

Explore Healthcare Insights

View Reports

Infertility Treatment Market